A股異動 | 英飛特(300582.SZ)放量漲停 前三季度淨利同比增長18.14%
格隆匯10月22日丨英飛特(300582.SZ)臨近午盤直線拉昇漲停,報19.68元創近三年新高,成交額放大至3.17億元,總市值38.9億元。英飛特日前公告,前三季實現營業收入7.06億元,與上年同期基本持平;實現歸母淨利潤7587.23萬元,同比增長18.14%。在克服2020年初新冠疫情對國內外市場的部分負面影響後,公司三季度呈現出快速增長態勢,並推動前三季度業績創造新高。值得注意的是,公司經營性現金淨額同比增長三成,收益質量顯著提高。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.